Stem cells injected into spine to fight rare disease Flare-Up
Disease control
Not yet recruiting
This early-phase trial tests whether injecting stem cells from a relative's bone marrow into the spine is safe for people with a severe relapse of neuromyelitis optica spectrum disorder (NMOSD), a rare autoimmune disease that attacks the optic nerves and spinal cord. Only 6 adult…
Phase: PHASE1 • Sponsor: Corestemchemon, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC